Volume 20 No 8 (2022)
Download PDF
Thymoquinone: Possible role in Treatment of Neurological Diseases
Samar Mahmoud Osama Lutfy, Azza Saad Ahmed Shehata, Samah Mohamed Ahmed, Maha Zayed Mohammed Hassan
Abstract
Nigella sativa (N. Sativa), well recognized as black cumin has been utilized as a
medicinal plant that has a strong traditional background. The seeds of N. sativa contain fixed oil,
essential oil, proteins, alkaloids and saponins. A good number of biologically active molecules are
also present, such as thymoquinone (TQ), flavonoids, α-hederin, alkaloids, antioxidants and fatty
acids which are good for a healthy well-being. Numerous laboratory research and clinical studies
have established that TQ exhibited a role in cancer management through the activation and
inactivation of molecular cascades. It exhibits killing of cancer cells through activation of tumoursuppressor gene, inhibition of angiogenesis and inhibition of transcription factor as well as enzymes
linked to cancer development and progression. The implications of TQ as an antitumor agent were
studied based on breast carcinoma and it was confirmed that it is an anti-proliferative agent.
Thymoquinone (TQ) possesses anticonvulsant, antianxiety, antidepressant, and antipsychotic
properties. It could be utilized to treat drug misuse or dependence, and those with memory and
cognitive impairment. TQ protects brain cells from oxidative stress, which is especially pronounced
in memory-related regions. TQ exhibits antineurotoxin characteristics, implying its role in
preventing neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease. TQ’s
antioxidant and anti-inflammatory properties protect brain cells from damage and inflammation.
Glutamate can trigger cell death by causing mitochondrial malfunction and the formation of reactive
oxygen species (ROS). Reduction in ROS production can explain TQ effects in neuroinflammation.
Keywords
Thymoquinone, Neurological Diseases
Copyright
Copyright © Neuroquantology
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.